Last reviewed · How we verify

NCT00178750

"Loss of Resistance" Versus CompuFlo® for Epidural Placement

Withdrawn Phase 1, PHASE2 Last updated 5 November 2020
What this trial tests

Phase 1, PHASE2 trial testing 18G Tuohy epidural needle in Pain. Withdrawn.

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhasePhase 1, PHASE2
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 65, female only, with Pain or Epidural Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare how well the CompuFlo® computerized syringe pump works as compared to the traditional method of inserting an epidural (a needle placed in one's back to give pain medicine).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00178750.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing